Related Experiment Video

Updated: Apr 25, 2026

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors
07:01

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

Published on: March 1, 2020

9.3K

The roles of CD73 in cancer

Zhao-wei Gao1, Ke Dong1, Hui-zhong Zhang1

  • 1Department of Clinical Diagnosis, Tangdu Hospital, Fourth Military Medical University, Xinsi Road, Xi'an, Shanxi 710038, China.

Biomed Research International
|August 16, 2014
PubMed

Insights

CD73, an enzyme overexpressed in many cancers, promotes tumor growth, spread, and immune evasion. Targeting CD73 (Cluster of Differentiation 73) offers a promising therapeutic strategy for cancer treatment.

Area of Science:

  • Biochemistry
  • Oncology
  • Immunology

Background:

  • Purinergic signaling regulates cancer progression via nucleotidases.
  • CD73 (Cluster of Differentiation 73) catalyzes AMP to adenosine, and is overexpressed in numerous cancers.
  • CD73 plays a key role in cancer cell proliferation, migration, invasion, angiogenesis, and immune escape.

Purpose of the Study:

  • To review the multifaceted roles of CD73 in cancer development.
  • To discuss the clinical significance and regulatory mechanisms of CD73 expression.
  • To summarize current anti-CD73 cancer therapy strategies.

Main Methods:

  • Literature review of studies on CD73 in cancer.
  • Analysis of CD73's impact on tumor growth, metastasis, angiogenesis, and immune response.
  • Evaluation of CD73 expression regulation and therapeutic targeting.

Main Results:

  • CD73 overexpression is linked to increased cancer cell proliferation, migration, and invasion.
  • CD73 promotes tumor angiogenesis and facilitates immune evasion.
  • Targeted blockade of CD73 shows potential as a future cancer therapy in preclinical models.

Conclusions:

  • CD73 is a critical regulator of cancer progression and a significant therapeutic target.
  • Understanding CD73's roles and regulation is crucial for developing effective anti-cancer therapies.
  • Inhibition of CD73 represents a promising strategy for future cancer treatment.

More Related Videos

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

53.3K
Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma12:16

Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma

Published on: March 13, 2013

20.8K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

2.0K